Immuron IMRN
NASDAQ IMRN
$0.95 -0.02 (-2.06%)
At close: Oct 22, 2026 · 4:00 PM EDT

Immuron (IMRN) Accumulated Expenses (2023 - 2026)

Updated

Immuron (IMRN) posted Accumulated Expenses of $309,081 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 2.1% from $315,639 a year earlier.

Analysis

Immuron (IMRN) Accumulated Expenses (2023 - 2026) Analysis & Trends

At the end of FY2026 (ended Jun 30, 2026), Immuron's Accumulated Expenses came in at $295,925, down 7.4% from FY2025.

  • Annual Accumulated Expenses shows a three-year compound annual growth rate of 3.7% (FY2023 to FY2026).
  • In prior fiscal years, Immuron's Accumulated Expenses was $319,432 in FY2025 (-66.3%), $947,996 in FY2024 (+257.3%) and $265,344 in FY2023.
  • The fiscal Q4 2026 figure stands as the lowest quarterly Accumulated Expenses since fiscal Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Immuron 7.67 Mn -9.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 299,881.23
Jun 30, 2025 321,991.46
Jun 30, 2024 961,311.53
Jun 30, 2023 260,833.82
API Access

Immuron Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IMRN&period=max&api_key=YOUR_API_KEY